Fund holders13F
Funds That Own Vaxcyte, Inc. (PCVX)
2 of the 26 major funds we track reported PCVX in their latest 13F, worth $4.06M combined at quarter end.
| Fund | Quarter | Shares | Value | Change |
|---|---|---|---|---|
| Bridgewater Associates | Q2 2026 | 50,217 | $2.92M | ▲ +289.2% |
| Renaissance Technologies | Q2 2026 | 19,634 | $1.14M | ▼ −64.1% |
| Baupost Group | Q2 2026 | 0 | $0 | ▼ Sold out |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
A 13F lists long positions in U.S.-listed stocks and some options at quarter end. It does not show short positions, cash, most foreign holdings, or trades made since. What a 13F can't tell you →